Get to know Romosozumab better with 2 real example sentences, the meaning.
Romosozumab in a sentence
Romosozumab meaning
An antibody used to treat osteoporosis
Using Romosozumab
- The main meaning on this page is: An antibody used to treat osteoporosis
Context around Romosozumab
- Average sentence length in these examples: 24.5 words
- Position in the sentence: 1 start, 1 middle, 0 end
- Sentence types: 2 statements, 0 questions, 0 exclamations
Corpus analysis for Romosozumab
- In this selection, "romosozumab" usually appears near the start of the sentence. The average example has 24.5 words, and this corpus slice is mostly made up of statements.
- Around the word, level and produced stand out and add context to how "romosozumab" is used.
- Recognizable usage signals include romosozumab is highly and tissue level romosozumab produced an. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "romosozumab" sits close to words such as aabb, aabria and aacha, which helps place it inside the broader word index.
Example types with romosozumab
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Romosozumab is highly effective at treating this condition by blocking the protein sclerostin, which is produced by bone cells and negatively impacts bone density. (24 words)
The analysis showed that at the tissue level, romosozumab produced an early and transient increase in bone formation and a persistent decrease in bone resorption. (25 words)
The analysis showed that at the tissue level, romosozumab produced an early and transient increase in bone formation and a persistent decrease in bone resorption. (25 words)
Romosozumab is highly effective at treating this condition by blocking the protein sclerostin, which is produced by bone cells and negatively impacts bone density. (24 words)
Example sentences (2)
Romosozumab is highly effective at treating this condition by blocking the protein sclerostin, which is produced by bone cells and negatively impacts bone density.
The analysis showed that at the tissue level, romosozumab produced an early and transient increase in bone formation and a persistent decrease in bone resorption.